David Kelly

David George Kelly currently works at Iterum Therapeutics Plc, as Chairman from 2025, Horizon Therapeutics Ireland DAC, as Director, Iterum Therapeutics International Ltd., as Director, Iterum Therapeutics US Holding Ltd., as Director, Iterum Therapeutics Bermuda Ltd., as Director, and The Institute of Chartered Accountants in Ireland, as Member.
Mr. Kelly also formerly worked at hVIVO PLC, as Independent Non-Executive Director from 2019 to 2020, Elan Corp.
Plc, as Principal, Warner Chilcott Plc, as Chief Financial Officer, AGI Therapeutics Plc, as CFO, Secretary & Head-Investor Relations in 2011, Horizon Therapeutics Ltd. (Ireland), as Secretary & Executive VP, MD-Ireland from 2014 to 2018, KPMG LLP, as Principal, and HZNP USA LLC, as Chief Financial Officer.
Mr. Kelly received his undergraduate degree from Trinity College Dublin.